185 related articles for article (PubMed ID: 35346069)
41. Clinicopathologic characteristics in patients with upper third gastric cancer following radical surgical treatment: A retrospective cohort study.
Ma X; Zhou W; Wang C; Miao W; Liu N; Wang S; Guan S
Medicine (Baltimore); 2018 Nov; 97(45):e13017. PubMed ID: 30407293
[TBL] [Abstract][Full Text] [Related]
42. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of MMP14 predicts the poor prognosis in gastric cancer: Meta-analysis and database validation.
Wang X; Meng Q; Wang Y; Gao Y
Medicine (Baltimore); 2021 Aug; 100(32):e26545. PubMed ID: 34397871
[TBL] [Abstract][Full Text] [Related]
44. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
[TBL] [Abstract][Full Text] [Related]
45. Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis.
Li LF; Wei ZJ; Sun H; Jiang B
World J Gastroenterol; 2014 Sep; 20(34):12313-21. PubMed ID: 25232267
[TBL] [Abstract][Full Text] [Related]
46. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
Zhang M; Dong Y; Liu H; Wang Y; Zhao S; Xuan Q; Wang Y; Zhang Q
Sci Rep; 2016 Nov; 6():37933. PubMed ID: 27892511
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.
Gu X; Gao XS; Ma M; Qin S; Qi X; Li X; Sun S; Yu H; Wang W; Zhou D
Oncotarget; 2016 Oct; 7(43):69666-69673. PubMed ID: 27626167
[TBL] [Abstract][Full Text] [Related]
48. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
49. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of increased expression of RBM8A in gastric cancer.
Lv X; Cheng H
Braz J Med Biol Res; 2020; 53(4):e9290. PubMed ID: 32294703
[TBL] [Abstract][Full Text] [Related]
51. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
52. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
53. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathological significance and prognostic role of microvessel density in gastric cancer: A meta-analysis.
Hong WG; Ko YS; Pyo JS
Pathol Res Pract; 2017 Dec; 213(12):1459-1463. PubMed ID: 29129495
[TBL] [Abstract][Full Text] [Related]
55. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
Zu G; Ji A; Zhou T; Che N
Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
[TBL] [Abstract][Full Text] [Related]
58. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis.
Liu G; Xiong D; Zeng J; Chen B; Huang Z
Onco Targets Ther; 2017; 10():4321-4328. PubMed ID: 28919781
[TBL] [Abstract][Full Text] [Related]
60. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
